Gallium-mediated siderophore quenching as an evolutionarily robust antibacterial treatment
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVES: Conventional antibiotics select strongly for resistance and are consequently losing efficacy worldwide. Extracellular quenching of shared virulence factors could represent a more promising strategy because (i) it reduces the available routes to resistance (as extracellular action precludes any mutations blocking a drug's entry into cells or hastening its exit) and (ii) it weakens selection for resistance, as fitness benefits to emergent mutants are diluted across all cells in a cooperative collective. Here, we tested this hypothesis empirically. METHODOLOGY: We used gallium to quench the iron-scavenging siderophores secreted and shared among pathogenic Pseudomonas aeruginosa bacteria, and quantitatively monitored its effects on growth in vitro. We assayed virulence in acute infections of caterpillar hosts (Galleria mellonella), and tracked resistance emergence over time using experimental evolution. RESULTS: Gallium strongly inhibited bacterial growth in vitro, primarily via its siderophore quenching activity. Moreover, bacterial siderophore production peaked at intermediate gallium concentrations, indicating additional metabolic costs in this range. In vivo, gallium attenuated virulence and growth-even more so than in infections with siderophore-deficient strains. Crucially, while resistance soon evolved against conventional antibiotic treatments, gallium treatments retained their efficacy over time. CONCLUSIONS: Extracellular quenching of bacterial public goods could offer an effective and evolutionarily robust control strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, gallium (Ga2+) quenching of P. aeruginosa siderophores reduced pathogenesis in a Galleria mellonella model and retained efficacy longer than the conventional antibiotics gentamicin and ciprofloxacin (118).”
From Transition Metals and Virulence in Bacteria (2016) · cites this paper as [118]
Experimental — accuracy not yet measuredIn the citing paper
“For example, gallium (Ga2+) quenching of P. aeruginosa siderophores reduced pathogenesis in a Galleria mellonella model and retained efficacy longer than the conventional antibiotics gentamicin and ciprofloxacin (118).”
From Transition Metals and Virulence in Bacteria (2016) · cites this paper as [118]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
Antibiotics for Emerging Pathogens
Fischbach, M. A., & Walsh, C. T. (2009) · Science · doi:10.1126/science.1176667 · Cited by 1,777 · cited 1×
“Consequently, the therapy will lose efficacy [1, 2].”
Siderophore-Based Iron Acquisition and Pathogen Control
Miethke, M., & Marahiel, M. A. (2007) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00012-07 · Cited by 1,774 · cited 1×
“Siderophores are diffusible molecules with a high affinity for ferric iron (Fe3þ) and are secreted by most bacteria to scavenge this important but generally bio-unavailable form of iron from their environment or, in the case of pathogens, from their host’s own iron-chelating compounds [17].”
BackgroundAnti-virulence strategies to combat bacteria-mediated disease
Rasko, D. A., & Sperandio, V. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3013 · Cited by 1,373 · cited 2×
“‘Antivirulence’ treatments, meanwhile, ostensibly disarm but do not harm pathogens, such that resistant variants should benefit little relative to susceptibles [4].”
BackgroundCooperation and competition in pathogenic bacteria
Griffin, A. S., West, S. A., & Buckling, A. (2004) · Nature · doi:10.1038/nature02744 · Cited by 1,104 · cited 1×
“Low (a) Pyoverdine molecules are shared across the local community [47], so producers of the novel and the ancestral pyoverdine types would benefit similarly.”
Adaptive and Mutational Resistance: Role of Porins and Efflux Pumps in Drug Resistance
Fernández, L., & Hancock, R. E. W. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00043-12 · Cited by 892 · cited 1×
“modified membrane properties to block a drug’s entry into a cell, or upregulated efflux pumps to hasten its exit [15]).”
BackgroundExploiting Quorum Sensing To Confuse Bacterial Pathogens
LaSarre, B., & Federle, M. J. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00046-12 · Cited by 820 · cited 1×
“Quorum quenching (QQ), which disrupts the cell-to-cell communication [quorum sensing (QS)] [9] underlying a wide range of collectively expressed virulence traits, is a PG-targeting ‘antivirulence’ therapy regarded as a promising alternative to conventional bacteriocidal or bacteriostatic treatments [10, 11].”
BackgroundIron and Pseudomonas aeruginosa biofilm formation
Banin, E., Vasil, M. L., & Greenberg, E. P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504266102 · Cited by 801 · cited 1×
“Cornelis, Free University of Brussels, Belgium, as well as versions of the above strains constitutively expressing GFP (PAO1-gfp, PAO1 pvdD-gfp, chromosomal insertion: attTn7::ptac-gfp), and a version of PAO1 with a pvdA-gfp reporter fusion (PAO1pvdA-gfp, chromosomal insertion: attB::pvdA-gfp) [27], provided by P.”
Where will new antibiotics come from?
Walsh, C. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro727 · Cited by 755 · cited 1×
“In light of our results, we contend that this approach—and more generally the extracellular targeting of PGs—could curb microbial virulence in an evolutionarily robust manner, and therefore represents a promising alternative to our dwindling succession of traditional antibiotics [59–61].”
Background
Cited by
Langdon, A., Crook, N., & Dantas, G. (2016) · Genome Medicine · doi:10.1186/s13073-016-0294-z · Cited by 912
“Compounds that inactivate siderophores therefore represent an evolutionarily robust antivirulence strategy [133].”
BackgroundMultidrug evolutionary strategies to reverse antibiotic resistance
Baym, M., Stone, L. K., & Kishony, R. (2016) · Science · doi:10.1126/science.aad3292 · Cited by 710
Targeting virulence: can we make evolution-proof drugs?
Allen, R. C., Popat, R., Diggle, S. P., & Brown, S. P. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3232 · Cited by 532
Self-citationTransition Metals and Virulence in Bacteria
Palmer, L. D., & Skaar, E. P. (2016) · Annual Review of Genetics · doi:10.1146/annurev-genet-120215-035146 · Cited by 449
Applications of Metals for Bone Regeneration
Glenske, K., Donkiewicz, P., Köwitsch, A., Milosevic-Oljaca, N., Rider, P., Rofall, S., Franke, J., Jung, O., Smeets, R., Schnettler, R., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030826 · Cited by 247
“In this manner, gallium downregulates bacterial iron uptake and impairs bacterial growth [140].”
BackgroundInhibiting bacterial cooperation is an evolutionarily robust anti-biofilm strategy
Dieltjens, L., Appermans, K., Lissens, M., Lories, B., Kim, W., Van der Eycken, E. V., Foster, K. R., & Steenackers, H. P. (2020) · Nature Communications · doi:10.1038/s41467-019-13660-x · Cited by 204
Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections
Rangel-Vega, A., Bernstein, L. R., Mandujano-Tinoco, E. A., GarcÃa-Contreras, S. J., & GarcÃa-Contreras, R. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00282 · Cited by 168
“Interestingly, restricting gallium’s growth inhibitory effects by pyoverdine sequestration strongly decreases the development of bacterial resistance (Ross-Gillespie et al., 2014).”
BackgroundConsiderations and caveats in anti-virulence drug development
Maura, D., Ballok, A. E., & Rahme, L. G. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.06.001 · Cited by 159
Antimicrobial Activity of Gallium Compounds on ESKAPE Pathogens
Hijazi, S., Visaggio, D., Pirolo, M., Frangipani, E., Bernstein, L., & Visca, P. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00316 · Cited by 144
“, 2014), making the selection of Ga(III)-resistant cells less likely to occur compared with conventional antibiotic treatments (Ross-Gillespie et al., 2014), GaPPIX enters the cell through specialized heme-uptake systems (Stojiljkovic et al.”
BackgroundGallium Liquid Metal: Nanotoolbox for Antimicrobial Applications
Truong, V. K., Hayles, A., Bright, R., Luu, T. Q., Dickey, M. D., Kalantar‐Zadeh, K., & Vasilev, K. A. (2023) · ACS Nano · doi:10.1021/acsnano.3c06486 · Cited by 147
Collective sensing and collective responses in quorum-sensing bacteria
Popat, R., Cornforth, D. M., McNally, L., & Brown, S. P. (2015) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0882 · Cited by 127
Self-citationRezzoagli, C., Archetti, M., Mignot, I., Baumgartner, M., & Kümmerli, R. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000805 · Cited by 126
“Specifically, gallium cannot be reduced and thereby irreversibly binds to siderophores and hinders siderophore-mediated iron uptake [25,27].”
BackgroundMethodInfluentialSelf-citationBartell, J. A., Blazier, A. S., Yen, P., Thøgersen, J. C., Jelsbak, L., Goldberg, J. B., & Papin, J. A. (2017) · Nature Communications · doi:10.1038/ncomms14631 · Cited by 133
How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient
Hansen, E., Woods, R. J., & Read, A. F. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2001110 · Cited by 132
Gerdt, J. P., & Blackwell, H. E. (2014) · ACS Chemical Biology · doi:10.1021/cb5004288 · Cited by 117
Building the microbiome in health and disease: niche construction and social conflict in bacteria
McNally, L., & Brown, S. P. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0298 · Cited by 123
Self-citationSocial interactions in bacterial cell–cell signaling
Asfahl, K. L., & Schuster, M. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw038 · Cited by 127
Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis
Smith, W. D., Bardin, E., Cameron, L. P., Edmondson, C. L., Farrant, K. V., Martin, I., Murphy, R. A., Soren, O., Turnbull, A. R., Wierre-Gore, N., et al. (2017) · FEMS Microbiology Letters · doi:10.1093/femsle/fnx121 · Cited by 121
Can resistance against quorum-sensing interference be selected?
García‐Contreras, R., Maeda, T., & Wood, T. K. (2015) · The ISME Journal · doi:10.1038/ismej.2015.84 · Cited by 106
“(Ross-Gillespie et al., 2014).”
Quorum sensing protects bacterial co-operation from exploitation by cheats
Allen, R. C., McNally, L., Popat, R., & Brown, S. P. (2016) · The ISME Journal · doi:10.1038/ismej.2015.232 · Cited by 86
“Our data highlight the need to understand drug targets in detail to predict the evolutionary consequences of treatment with new therapeutics (Allen et al., 2014; Ross-Gillespie et al., 2014; Vale et al., 2014).”
BackgroundSelf-citationBeyond killing: Can we find new ways to manage infection?
Vale, P. F., McNally, L., Doeschl‐Wilson, A., King, K. C., Popat, R., Domingo-Sananes, M. R., Allen, J. E., Soares, M. P., & Kümmerli, R. (2016) · Evolution Medicine and Public Health · doi:10.1093/emph/eow012 · Cited by 85
“In this scenario resistant mutants might restore production of the drug-inhibited virulence factor or produce a modified, more potent, version of it [17,23].”
BackgroundInfluentialSelf-citationChampion, O. L., Titball, R. W., & Bates, S. (2018) · Journal of Fungi · doi:10.3390/jof4030108 · Cited by 91
Bilitewski, U., Blodgett, J. A. V., Duhme‐Klair, A., Dallavalle, S., Laschat, S., Routledge, A., & Schobert, R. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201701586 · Cited by 85
War and peace: social interactions in infections
Leggett, H. C., Brown, S. P., & Reece, S. E. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0365 · Cited by 79
Self-citationKircheva, N., & Dudev, T. (2020) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.0c00367 · Cited by 79
Drug resistance in cancer: molecular evolution and compensatory proliferation
Friedman, R. (2016) · Oncotarget · doi:10.18632/oncotarget.7459 · Cited by 77
Shapiro, J. A., & Wencewicz, T. A. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00145 · Cited by 72
Hansen, E., Karslake, J., Woods, R. J., Read, A. F., & Wood, K. B. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000713 · Cited by 69
Totsika, M. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0227 · Cited by 64
Deliormanlı, A. M. (2015) · Ceramics International · doi:10.1016/j.ceramint.2015.09.016 · Cited by 56
McAdams, D., Waldetoft, K. W., Tedijanto, C., Lipsitch, M., & Brown, S. P. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000250 · Cited by 56
Self-citationGlasses in bone regeneration: A multiscale issue
Salinas, A. J., & Vallet‐Regí, M. (2015) · Journal of Non-Crystalline Solids · doi:10.1016/j.jnoncrysol.2015.03.025 · Cited by 51
Granato, E. T., Ziegenhain, C., Marvig, R. L., & Kümmerli, R. (2018) · The ISME Journal · doi:10.1038/s41396-018-0231-9 · Cited by 45
Self-citationGranato, E. T., Harrison, F., Kümmerli, R., & Ross‐Gillespie, A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01952 · Cited by 45
“…Jimenez et al., 2010; Oliver, 2011; Romanowski et al., 2011; Feinbaum et al., 2012; Okuda et al., 2012; Imperi et al., 2013; Kirienko et al., 2013; Ross-Gillespie et al., 2014; Dubern et al., 2015; Lin et al., 2015; Lopez-Medina et al., 2015; Minandri et al., 2016, see also Tables S1, S2 in the…”
BackgroundSelf-citationRezzoagli, C., Granato, E. T., & Kümmerli, R. (2020) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001134 · Cited by 51
“Gallium is a repurposed drug that can enter the cells and interfere directly with iron metabolism at high concentrations (Hijazi et al., 2018), whereas at sub-toxic levels gallium primarily binds to and effectively quenches bacterial siderophores (Ross-Gillespie et al., 2014).”
BackgroundSelf-citationDesigning Ga( iii )-containing hydroxyapatite with antibacterial activity
Kurtjak, M., Vukomanović, M., Krajnc, A., Kramer, L., Turk, B., & Suvorov, D. (2016) · RSC Advances · doi:10.1039/c6ra23424k · Cited by 44
Adaptation to public goods cheats in Pseudomonas aeruginosa
O'Brien, S., Luján, A. M., Paterson, S., Cant, M. A., & Buckling, A. (2017) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2017.1089 · Cited by 45
Why Quorum Sensing Controls Private Goods
Schuster, M., Sexton, D. J., & Hense, B. A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00885 · Cited by 46
“Novel antivirulence strategies that target these behaviors have the potential to slow the evolution of resistance (Schuster et al., 2013; Allen et al., 2014; Ross-Gillespie et al., 2014).”
BackgroundFighting microbial drug resistance: a primer on the role of evolutionary biology in public health
Perron, G. G., Inglis, R. F., Pennings, P. S., & Cobey, S. E. (2015) · Evolutionary Applications · doi:10.1111/eva.12254 · Cited by 44
“Rather than trying to kill bacteria, these drugs modulate social interactions between microbes, selecting for less virulent variants (Brown et al. 2009; Ross-Gillespie et al. 2014).”
BackgroundExperimental evolution of gallium resistance in Escherichia coli
Graves, J. L., Ewunkem, A. J., Ward, J., Staley, C., Thomas, M. D., Rhinehardt, K. L., Han, J., & Harrison, S. H. (2019) · Evolution Medicine and Public Health · doi:10.1093/emph/eoz025 · Cited by 41
“Despite optimism concerning the sustainability of metallic antimicrobials [4, 5, 24], bacteria can also rapidly evolve resistance to these materials as well.”
BackgroundResultControl vs. eradication: Applying infectious disease treatment strategies to cancer
Jansen, G., Gatenby, R. A., & Aktipis, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420297111 · Cited by 36
Lorenz, A., Pawar, V., Häußler, S., & Weiß, S. (2016) · FEBS Letters · doi:10.1002/1873-3468.12454 · Cited by 38
Rezzoagli, C., Wilson, D., Weigert, M., Wyder, S., & Kümmerli, R. (2018) · Evolution Medicine and Public Health · doi:10.1093/emph/eoy026 · Cited by 33
“We hypothesize that gallium and flucytosine are likely to reduce pathogen fitness as they induce iron starvation [19, 23, 36, 37].”
InfluentialSelf-citationAn In Vitro Cell Culture Model for Pyoverdine-Mediated Virulence
Kang, D., & Kirienko, N. V. (2020) · Pathogens · doi:10.3390/pathogens10010009 · Cited by 37
How to kill Pseudomonas —emerging therapies for a challenging pathogen
Yaeger, L. N., Coles, V. E., Chan, D. C. K., & Burrows, L. L. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14596 · Cited by 36
Rezzoagli, C., Granato, E. T., & Kümmerli, R. (2019) · The ISME Journal · doi:10.1038/s41396-019-0442-8 · Cited by 36
Self-citationLópez-Jácome, L. E., Franco‐Cendejas, R., Quezada, H., Morales-Espinosa, R., Castillo‐Juárez, I., González‐Pedrajo, B., Fernández-Presas, A. M., Tovar-García, A., Angarita-Zapata, V., Licona-Limón, P., et al. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.04.016 · Cited by 34
Characterization of gallium resistance induced in a Pseudomonas aeruginosa cystic fibrosis isolate
Tovar-García, A., Angarita-Zapata, V., Cazares, A., Jasso‐Chávez, R., Belmont-Díaz, J., Sánchez-Torres, V., López-Jácome, L. E., Coria‐Jiménez, R., Maeda, T., & García‐Contreras, R. (2019) · Archives of Microbiology · doi:10.1007/s00203-019-01777-y · Cited by 33
“2013) (the reference strains used so far), probably because pyoverdine is a public good and any overproducing mutant will not benefit by its overproduction since the remaining population will also utilize the pyoverdine produced by the mutant, thus reducing the fitness of the mutant (Ross-Gillespie et al. 2014).”
BackgroundO’Shaughnessy, M., McCarron, P., Viganor, L., McCann, M., Devereux, M. M., & Howe, O. L. (2020) · Antibiotics · doi:10.3390/antibiotics9100674 · Cited by 28
“aeruginosa can develop resistance to gallium compared to the classic small molecule antibiotics [39].”
BackgroundScott, Z. W., Choi, S., Britigan, B. E., & Narayanasamy, P. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00050 · Cited by 28
Forging New Antibiotic Combinations under Iron-Limiting Conditions
Chan, D. C. K., Guo, I., & Burrows, L. L. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01909-19 · Cited by 25
Manipulating virulence factor availability can have complex consequences for infections
Weigert, M., Ross‐Gillespie, A., Leinweber, A., Pessi, G., Brown, S. P., & Kümmerli, R. (2016) · Evolutionary Applications · doi:10.1111/eva.12431 · Cited by 27
Self-citationEvolution of gallium applications in medicine and microbiology: a timeline
de Assis, A. S. J., Pegoraro, G. M., & Duarte, I. C. S. (2022) · BioMetals · doi:10.1007/s10534-022-00406-4 · Cited by 21
Caldeira, J. B., Chung, A. P., Morais, P. V., & Branco, R. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11254-6 · Cited by 22
“Although bacterial transporters of Ga are not clearly known, the similar chemical characteristics between both elements might allow siderophores binding to Ga and consequently entrance of this metal into the cells in iron absence, resulting in metabolic stress (Ross-Gillespie et al. 2014).”
BackgroundSeeding Public Goods Is Essential for Maintaining Cooperation in Pseudomonas aeruginosa
Loarca, D., Díaz, D., Quezada, H., Guzmán-Ortiz, A. L., Rebollar-Ruiz, A., Presas, A. M. F., Ramírez-Peris, J., Franco‐Cendejas, R., Maeda, T., Wood, T. K., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02322 · Cited by 19
An ecosystem framework for understanding and treating disease
Hochberg, M. (2018) · Evolution Medicine and Public Health · doi:10.1093/emph/eoy032 · Cited by 17
“[128]), resistance is a concern, and there may be limitations in their efficacy in vivo [117, 120, 121].”
BackgroundNovel Targets of Antimicrobial Therapies
Maddocks, S. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0018-2015 · Cited by 18
“Gallium is a redox-inactive metal that can replace iron in a number of biological iron compounds, including siderophores (15 – 17).”
BackgroundMicrobial Siderophores in Metal Detoxification and Therapeutics: Recent Prospective and Applications
Sharma, R., Bhardwaj, R., Gautam, V., Kohli, S. K., Kaur, P., Bali, R. S., Saini, P., Thukral, A. K., Arora, S., & Vig, A. P. (2018) · Microorganisms for sustainability · doi:10.1007/978-981-10-5514-0_15 · Cited by 20
The Evolution of Myelin: Theories and Application to Human Disease
Knowles, L. W. (2017) · Journal of Evolutionary Medicine · doi:10.4303/jem/235996 · Cited by 18
Lissens, M., Joos, M., Lories, B., & Steenackers, H. P. L. (2022) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuac019 · Cited by 14
“aeruginosa (Ross-gillespie et al. 2014) is evolutionarily robust, although it was not directly demonstrated that resistant strains were counter selected.”
BackgroundResultInfluentialLindsay, R. J., Jepson, A., Butt, L., Holder, P. J., Smug, B. J., & Gudelj, I. (2021) · Ecology Letters · doi:10.1111/ele.13861 · Cited by 16
Waldetoft, K. W., & Brown, S. P. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2003533 · Cited by 14
Self-citationThe evolution of bacterial social life: From the ivory tower to the front lines of public health
Pepper, J. W. (2014) · Evolution Medicine and Public Health · doi:10.1093/emph/eou010 · Cited by 13
Aljohani, A. M., Chami, C. E., Alhubail, M., Ledder, R. G., O’Neill, C. A., & McBain, A. J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1108273 · Cited by 13
“It has been reported that inhibiting iron sequestration in Pseudomonas aeruginosa using galliummediated quenching of pyoverdine siderophores reduced virulence and proliferation in a larval infection model (Ross-Gillespie et al., 2014).”
BackgroundCaldeira, J. B., Morais, P. V., & Branco, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-77447-7 · Cited by 14
Herron, M., Schurr, M. J., Murphy, C. J., McAnulty, J. F., Czuprynski, C. J., & Abbott, N. L. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500599 · Cited by 12
Pseudomonas aeruginosa in the Cystic Fibrosis Lung
King, J., Murphy, R. A., & Davies, J. C. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-08491-1_13 · Cited by 11
Recent Advances in Novel Antibacterial Development
(2016) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781681081533116020003 · Cited by 9
Synthetically engineered microbes reveal interesting principles of cooperation
Dressler, M. D., Clark, C. J., Thachettu, C. A., Zakaria, Y., Eldakar, O. T., & Smith, R. P. (2016) · Frontiers of Chemical Science and Engineering · doi:10.1007/s11705-016-1605-z · Cited by 11
“As such, this approach uses selection as a tool to disrupt cooperation without imposing selection for resistance [100,101].”
BackgroundMethodXiao, J., Bu, Y., Tao, Y., Zhou, Z., Zou, J., Cui, W., & Yang, Z. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s576272 · Cited by 10
Anti-virulence Therapy Against Bacterial Infections: Mechanisms of Action and Challenges
Ghazaei, C. (2021) · Journal of Kermanshah University of Medical Sciences · doi:10.5812/jkums.111808 · Cited by 8
“Prior research has demonstrated success through the mechanism of targeting specific regulatory steps in the regulation of virulence factors (50, 51).”
BackgroundGallium: a decisive “Trojan Horse” against microorganisms
de Assis, A. S. J., Pegoraro, G. M., Duarte, I. C. S., & Delforno, T. P. (2024) · Antonie van Leeuwenhoek · doi:10.1007/s10482-024-02015-2 · Cited by 9
“…highlights the importance of research with gallium in the development of strategies to combat opportunistic pathogens, such as P. aeruginosa , in clinical settings (Bonchi et al. 2014; Goss et al. 2018; Guo et al. 2019; Piatek et al. 2017; Ross-Gillespie et al. 2014; Tovar-Garcia et al. 2019).”
Dhouib, R., Vagenas, D., Hong, Y., Verderosa, A. D., Martin, J. L., Heras, B., & Totsika, M. (2021) · FASEB BioAdvances · doi:10.1096/fba.2020-00100 · Cited by 8
“Emerging experimental evidence (16, 17, 57, 58), appears to support the theoretical prediction that evolution of resistance to antivirulence drugs will largely depend on the virulence factor targeted, and will thus differ considerably for different antivirulence drugs (14, 15).”
Background'Evolution-Proofing' Antibacterials
Ross‐Gillespie, A., & Kümmerli, R. (2014) · Evolution Medicine and Public Health · doi:10.1093/emph/eou020 · Cited by 8
Self-citationSong, T., Zhao, X., Shao, Y., Guo, M. Z., Li, C., & Zhang, W. (2019) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1903.03008 · Cited by 9
Bilitewski, U., Blodgett, J. A. V., Duhme‐Klair, A., Dallavalle, S., Laschat, S., Routledge, A., & Schobert, R. (2017) · Angewandte Chemie · doi:10.1002/ange.201701586 · Cited by 7
Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy
Cazzaniga, G., Mori, M., Griego, A., Scarpa, E., Moschetti, G., Muzzioli, S., Stelitano, G., Chiarelli, L. R., Cocorullo, M., Casali, E., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02386 · Cited by 6
Social Evolution: Slimy Cheats Pay a Price
O’Brien, S., & Brockhurst, M. A. (2015) · Current Biology · doi:10.1016/j.cub.2015.03.018 · Cited by 6
Ehsani, S. (2020) · Future of business and finance · doi:10.1007/978-3-030-41309-5_13 · Cited by 10
Challenges and opportunities for cheat therapy in the control of bacterial infections
Gurney, J., Simonet, C., Waldetoft, K. W., & Brown, S. P. (2022) · Natural Product Reports · doi:10.1039/d1np00053e · Cited by 5
Self-citationA framework for philosophical biologyPreprint
Ehsani, S. (2016) · arXiv (Cornell University) · doi:10.48550/arxiv.1605.00033 · Cited by 4
“Another example of the usage of sound theoretical arguments in advance of establishing an experimental paradigm is the recent focus on siderophore quenching strategies to avoid the emergence of antibiotic resistance in a bacterial community [49], which in essence shift the burden of antibiotic resistance from individu…”
BackgroundShort-range C-signaling restricts cheating behavior during Myxococcus xanthus development
Hoang, Y., Franklin, J. L., Dufour, Y. S., & Kroos, L. (2024) · mBio · doi:10.1128/mbio.02440-24 · Cited by 4
2-Aminoimidazoles as potent inhibitors of contaminating brewery biofilms
Jacobs, L., Meesters, J., Parijs, I., Hooyberghs, G., der Eycken, E. V. V., Lories, B., & Steenackers, H. P. L. (2021) · Biofouling · doi:10.1080/08927014.2021.1874366 · Cited by 3
Burke, K. J., Duffin, R. N., & Andrews, P. C. (2025) · Dalton Transactions · doi:10.1039/d5dt02012c · Cited by 2
The bacterial communication system and its interference as an antivirulence strategy
Aggarwal, S., Mahajan, P., Gupta, P., Yadav, A., Dhawan, G., Dhawan, U., & Yadav, A. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91806-0.00010-2 · Cited by 3
Hills, O. J., Poskrobko, Z., Scott, A. J., Smith, J., & Chappell, H. F. (2023) · PLoS ONE · doi:10.1371/journal.pone.0287191 · Cited by 2
“siderophore activity in relation to gallium exposure have found a positive correlation with anti-growth activity, suggesting an interesting association between gallium activity and siderophore quenching [30].”
BackgroundO'Sullivan, T., Karakoç, C., Waldetoft, K. W., & Brown, S. P. (2025) · mSphere · doi:10.1128/msphere.00953-24 · Cited by 4
Self-citationHuman Gustation: When the Brain Has Taste
Toepel, U., & Murray, M. M. (2015) · Current Biology · doi:10.1016/j.cub.2015.03.002 · Cited by 2
Kumar, A., & Han, S. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816909-4.00013-0 · Cited by 2
Darwinian Strategies to Avoid the Evolution of Drug Resistance During Cancer Treatment
Pepper, J. W. (2016) · Springer eBooks · doi:10.1007/978-3-319-29716-3_12 · Cited by 1
Controlling Rogue Cells in Cancer and Bacterial Infections
Waldetoft, K. W., McDonald, J. F., & Brown, S. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804310-3.00021-1 · Cited by 1
Self-citationNovel Targets of Antimicrobial Therapies
Maddocks, S. (2016) · ASM Press eBooks · doi:10.1128/9781555819286.ch26 · Cited by 1
Tamba, S., Panicker, A., Jobby, R., Rajasekharan, S. K., Shanmugam, K., & Ravichandran, V. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95715-1.00017-0 · Cited by 2
Hills, O. J., Noble, I. O. K., Heyam, A., Scott, A. J., Smith, J., & Chappell, H. F. (2023) · Microbiology · doi:10.1099/mic.0.001422 · Cited by 1
Applying evolutionary thinking in the clinic
Stearns, S. C., & Medzhitov, R. M. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780192871978.003.0015 · Cited by 1
Rezzoagli, C., Wilson, D., Weigert, M., Wyder, S., & Kümmerli, R. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/195974 · Cited by 1
Self-citationRezzoagli, C., Archetti, M., Mignot, I., Baumgartner, M., & Kümmerli, R. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/861799 · Cited by 1
Self-citationThe Role of Theory in Cancer Research
Pepper, J. W. (2016) · doi:10.1007/978-1-4939-6460-4_2
Read, A. F. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2003250
Properties of a Gallium-Conjugated Siderophore Complex as an Antibacterial Treatment
Cendo, D. Z., Enkeshafi, P., Han, P. W., Harner, C. R., Herman, R. J., Huffman, M. P., Lee, F. C., Liu, Q. T., & Nguyen, C. P. (2018) · University Libraries (University of Maryland) · doi:10.13016/m23b5wb7j
“In our experiment, we used desferrioxamine B (DFO-B) as our siderophore and gallium as our metallic ion, but the same principles apply because gallium has many of the same properties as iron (Ross-Gillespie et al., 2014).”
BackgroundMethodResultInfluential
Metadata
- Authors
- Ross-Gillespie, A., Weigert, M., Brown, S. P., & Kümmerli, R.
- Affiliations
- University of Zurich (CH)
- Venue
- Evolution, Medicine, and Public Health
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-01-01
- Volume
- 2014
- Issue
- 1
- Pages
- 18-29
- ISSN
- 2050-6201 (ISSN-L)
- PMC
- PMC3935367
- OpenAlex
- W2157642827
- Cited by
- 104
- References
- 63
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 4 · 2021: 8 · 2020: 12 · 2019: 9 · 2018: 7 · 2017: 13 · 2016: 18 · 2015: 12 · 2014: 6
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Evolution Medicine and Public Health (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
- DORA Eawag (Swiss Federal Institute of Aquatic Science and Technology (Eawag)) (submittedVersion, cc-by)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antimicrobial agents and applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- gallium, Pseudomonas aeruginosa, antibiotic resistance, virulence attenuation, Galleria mellonella, experimental evolution, public goods, iron acquisition, antibiotic therapy, bacterial virulence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.